Quick Facts

• Primary Use: Management of type 2 diabetes mellitus.
• Therapeutic Domain: Used to support blood glucose control.
• Treatment Context: Applied when diet and increased physical activity alone are inadequate.
• Regimen Options: May be used as a standalone treatment (monotherapy) or in combination with other oral diabetes medications or insulin.

---

Siofor (metformin) is indicated for the management of type 2 diabetes mellitus in adults. Its central purpose is to help improve blood glucose regulation. This medication is primarily used in individuals whose blood sugar levels are not adequately addressed by dietary changes and increased physical activity alone. It may be considered a component of a comprehensive treatment plan that seeks to improve overall metabolic control.

For adults, Siofor may be utilized as the first medication (monotherapy) or may be administered alongside other therapeutic options, including other oral agents or insulin, to support the achievement of target blood sugar levels. Therapeutic use is often observed in patients, particularly those with associated overweight status. Improved blood sugar management may help to mitigate the risk of serious long-term health complications associated with type 2 diabetes.

In pediatric patients (children and adolescents from 10 years of age), Siofor may also be prescribed as a monotherapy or in combination with insulin for the treatment of type 2 diabetes. The therapeutic benefits center on enhancing the body's response to insulin and assisting with glucose balance.

Who Can and Cannot Use Siofor 500/850/1000?

Eligibility for Siofor (Metformin Hydrochloride) is strictly defined by regulatory authorities based on age, organ function, and specific medical conditions.

Approved Populations

Siofor is officially approved for the management of Type 2 Diabetes Mellitus in adults and children from 10 years of age and older. It may be used as a standalone treatment or in combination with other anti-diabetic medications.

Absolute Contraindications (Must Not Use)

Use of Siofor is prohibited under the following conditions as stated in regulatory labels:

• Severe renal impairment (kidney function below an estimated GFR of 30 mL/ min).
• Acute metabolic acidosis, including diabetic ketoacidosis or lactic acidosis.
• Hepatic insufficiency (liver impairment).
• Hypersensitivity (allergy) to Metformin.
• Acute conditions that can cause tissue hypoxia (low oxygen levels), such as unstable congestive heart failure or respiratory failure.
• Children under 10 years of age.

Restricted Use and Conditional Status

Therapy requires temporary interruption for certain medical procedures, including radiological studies using iodinated contrast materials and major surgery. Geriatric patients require more frequent monitoring of kidney function due to age-related decline.

Siofor (Metformin) interactions are defined by the potential for drug accumulation due to reduced renal clearance and the modification of its primary effect on blood glucose. The most stringent constraints involve agents and procedures that acutely affect kidney function, as Metformin is eliminated unchanged by the kidneys.

Interaction Type	Interacting Substances/Context
Procedural Restriction	Iodinated Contrast Materials (Intravascular)
Exposure Increase (PK)	Renal Transporter Inhibitors (e.g., Cimetidine, Ranolazine, Dolutegravir)
Glycemic Modification (PD)	Glucose-Lowering Agents (e.g., Sulfonylureas)
	Hyperglycaemic Agents (e.g., Glucocorticoids)
Substance Interaction	Excessive Alcohol Intake
	Vitamin B12

For procedures involving iodinated contrast materials, regulatory labeling mandates temporary discontinuation at the time of or prior to the procedure, with the drug to be withheld for 48 hours afterward, pending re-evaluation of renal function. Co-administration with renal transporter inhibitors may increase Metformin plasma concentrations by inhibiting its clearance via the renal tubular transporters (OCT2/MATE). The profile notes that hepatic impairment is a factor that increases the risk associated with Metformin accumulation, often leading to the avoidance of use as a regulatory restriction.

How Siofor (Metformin) Works: Mechanism of Action

Siofor, an antihyperglycemic agent, modulates core metabolic signaling pathways across three main physiological domains. The primary action begins in the liver, where Metformin is transported into hepatocytes via Organic Cation Transporters (OCTs). The drug acts as a weak inhibitor of Mitochondrial Complex I, causing a shift in cellular energy (increased AMP:ATP ratio) which activates the key regulatory enzyme AMP-activated protein kinase (AMPK). The activated AMPK suppresses essential enzymes required for the liver's glucose synthesis process (gluconeogenesis), leading to a reduction in hepatic glucose output.

Beyond the liver, Metformin improves the efficiency of insulin signaling in peripheral tissues, such as skeletal muscle. This action, also mediated by AMPK activation, promotes the movement of glucose transporters (GLUT4) to the cell surface, increasing the cellular uptake of glucose from the circulation. This mechanism enhances the tissue's utilization of its existing insulin, leading to enhanced clearance of glucose from the circulation after meals. The drug also accumulates in the intestine, where it modulates the rate at which glucose is absorbed into the circulation, which further contributes to the comprehensive systemic modulation of glucose.

How to Use Siofor 500/850/1000: Official Administration Guidelines

Siofor, which contains Metformin Hydrochloride (Metformin HCl), is administered exclusively via the oral route as an immediate-release tablet. Proper administration is structured by regulatory standards to ensure correct dosing and tolerance.

---

Standard Dosing and Schedule

The treatment is initiated with a low dose and gradually adjusted. The official starting dose for adults is 500 mg twice daily or 850 mg once daily, taken with meals. The dose is typically increased (titrated) in increments of 500 mg weekly or 850 mg every two weeks, based on official instructions. The dose is usually administered in two or three divided doses per day, with the maximum recommended daily dose being 2550 mg in the U.S. and up to 3000 mg in Europe.

---

Administration Conditions and Adjustments

Administration Condition	Official Instruction
Timing with Meals	Take the tablets with meals (or during/after) to optimize tolerability.
Missed Dose	If a dose is missed, skip the missed dose and take the next scheduled dose at the usual time. Do not double the dose.
Pediatric Use	For children 10 years of age or older, the starting dose is 500 mg twice daily, with a maximum daily dose of 2000 mg in divided doses.
Renal Function	Dosing must be adjusted based on estimated glomerular filtration rate (eGFR). Use is not recommended if eGFR falls between 30 to 45 mL/ min, and it is contraindicated if eGFR is below 30 mL/ min/ 1.73 m^2.

---

The long-term use protocol requires tablets to be swallowed whole and involves the temporary discontinuation of the medicine prior to specific medical procedures, such as those involving iodinated contrast agents, with recommencement only after renal function is stable.

Research evidence / Overview of Studies for Siofor 500/850/1000

---

Evidence for Blood Sugar Control in Type 2 Diabetes

Siofor (Metformin) was evaluated in research exploring high blood sugar, utilizing many Randomized Controlled Trials (RCTs) and systematic reviews. These short-term trials, typically 13 to 26 weeks, focused on how specific blood sugar markers like Glycosylated Hemoglobin (HbA1c) and Fasting Plasma Glucose (FPG) evolved in adults with the condition. Studies exploring outcomes related to systemic imbalance reported how these markers evolved, with findings describing patterns related to blood sugar control. The research provides insight into short-term changes, but comparative evidence is lacking against other available treatments that have been studied for cardiovascular outcomes.

---

Research on Long-Term Outcomes and Complications

Key research examining long-term outcomes was conducted via a single, large-scale Prospective Randomized Controlled Trial (UKPDS) with extended post-trial follow-up. This research examined clinical endpoints related to mortality measures and major cardiovascular events, including All-cause mortality and Myocardial Infarction. The study specifically included overweight or obese adults with newly diagnosed T2DM. The evidence base for the long-term impact on major cardiovascular events is largely derived from this single, older trial, and results apply only to the specific population studied.

---

Evidence in Specific Patient Groups and Remaining Uncertainty

Research has explored the use of Metformin in pediatric patients (children and adolescents from 10 years of age), describing how outcomes evolved when used as a single treatment or in scenarios involving combination with insulin. Studies also evaluated its use in Prediabetes, monitoring the incidence rate of T2DM. The findings were mixed, and overall certainty remains low across all groups studied for prevention.

Data for certain groups, such as older adults, remain insufficient or primarily observational. The long-term effects for the general T2DM population are not fully established, and research is ongoing to address these limitations.

Key Studies & References

1. Label: Metformin Hydrochloride extended-release tablets - Prescribing Information (US FDA)

Common questions about Siofor 500/850/1000 (FAQ)

---

Q: What is Siofor 500/850/1000, and what is it used for?

Siofor contains the active ingredient metformin hydrochloride and is a medication belonging to the group called biguanides. According to regulatory product information, it is indicated for the treatment of type 2 diabetes mellitus, particularly in patients who are overweight, when diet and exercise alone have not provided adequate control of blood sugar levels. It may be used alone or in combination with other anti-diabetic medications or insulin.

---

Q: How does Siofor work to help manage blood sugar?

Siofor (metformin) primarily works by reducing the amount of glucose produced by the liver. It is also thought to help the body respond better to insulin, the hormone that helps move sugar from the blood into the cells. This action supports the overall goal of achieving and maintaining stable blood glucose concentrations, which is essential in managing type 2 diabetes.

---

Q: Is it common to experience side effects when starting Siofor?

As with most medications, Siofor may be associated with side effects. Gastrointestinal symptoms are commonly reported, especially when treatment is first initiated. These may include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite. Often, these effects can diminish over time. Product labeling indicates that taking the medicine with meals may help manage these symptoms. A very rare, but serious, risk is lactic acidosis.

---

Q: What is the risk of lactic acidosis while taking Siofor?

Lactic acidosis is a very rare but potentially serious complication that has been associated with metformin treatment. This condition is characterized by an excessive buildup of lactic acid in the blood and requires immediate medical attention. Factors that may increase this risk include severe kidney impairment, excessive alcohol intake, and acute conditions like severe dehydration or heart failure. Patients should be aware of symptoms and consult a healthcare professional immediately if they suspect this complication.

---

Q: Can Siofor be taken with other medications?

Siofor may interact with several other medications, and these combinations may require medical supervision or dose adjustments. It is important to inform your prescribing healthcare provider about all other medications, supplements, and herbal remedies you are currently taking. Specific interactions may exist with medicines like diuretics, corticosteroids, and certain blood pressure medications.

---

Q: What should I do if I miss a dose of Siofor?

If a dose is missed, regulatory information generally suggests skipping the missed dose and taking the next scheduled dose at the usual time. It is important not to take a double dose to make up for a forgotten one. For specific guidance tailored to your treatment plan, a conversation with a healthcare provider is recommended.

---

Q: How long does it take for Siofor to start having an effect?

The effect of Siofor on blood glucose may not be immediate. While the medicine begins working in the body relatively quickly, the full and sustained benefit in terms of overall blood sugar management typically develops over several weeks of consistent use. Regular monitoring and follow-up with a healthcare provider are necessary to assess the medication's effectiveness in achieving therapeutic goals.

How to Store and Dispose of Siofor 500/850/1000?

---

Storage Requirements

Siofor (metformin hydrochloride) tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. To maintain stability, the tablets must be stored in the original container. It is a mandatory requirement to keep Siofor out of the sight and reach of children.

---

Disposal Instructions

Disposal of any unused Siofor product or waste material must be managed in accordance with local requirements. Official guidance specifies that the medicine must not be disposed of via wastewater or regular household waste to prevent environmental contamination.